Wonbiogen Co., Ltd. (KOSDAQ:307280)
South Korea · Delayed Price · Currency is KRW 6,070.00
+290.00 (5.02%)
At close: Aug 11, 2026
Wonbiogen Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 36,270 | 35,244 | 30,440 | 29,615 | 26,748 | 17,721 |
Revenue Growth | 14.69% | 15.78% | 2.79% | 10.72% | 50.94% | 47.46% |
Gross Profit Gross Profit Growth | 18,679 | 17,769 | 14,238 | 14,146 | 12,423 | 7,548 |
Operating Income Operating Income Growth | 8,777 | 8,192 | 6,216 | 7,038 | 5,050 | 2,040 |
Net Income Net Income Growth | 7,042 | 6,615 | 5,690 | 5,497 | 3,206 | -716.2 |
Earnings Per Share EPS Growth | 998.92 | 932.80 | 802.00 | 725.00 | 445.00 | -105.00 |
EPS Growth | 20.72% | 16.31% | 10.62% | 62.92% | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13,390 | 15,360 | 10,870 | 8,556 | 8,573 | 13,758 |
Total Debt Total Debt Growth | 2,440 | 930.65 | 892.23 | 7,318 | 9,201 | 8,089 |
Net Cash (Debt) Net Cash Growth | 10,950 | 14,430 | 9,978 | 1,238 | -628.38 | 5,669 |
Net Cash Growth | 1.55% | 44.61% | 705.69% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1553.22 | 2034.66 | 1406.50 | 162.84 | -87.33 | 816.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 9,850 | 8,483 | 8,850 | 4,835 | 5,782 | 1,082 |
Capital Expenditures CapEx Growth | -6,445 | -1,972 | -648.41 | -1,646 | -6,494 | -2,336 |
Free Cash Flow Free Cash Flow Growth | 3,405 | 6,512 | 8,201 | 3,189 | -711.95 | -1,254 |
Free Cash Flow Growth | -50.44% | -20.60% | 157.16% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 51.50% | 50.42% | 46.77% | 47.77% | 46.44% | 42.59% |
Operating Margin | 24.20% | 23.24% | 20.42% | 23.76% | 18.88% | 11.51% |
Pretax Margin | 23.41% | 22.08% | 21.10% | 24.17% | 13.71% | -4.49% |
Profit Margin | 19.42% | 18.77% | 18.69% | 18.56% | 11.99% | -4.04% |
FCF Margin | 9.39% | 18.48% | 26.94% | 10.77% | -2.66% | -7.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 140.000 | - | - | 100.000 | 50.000 |
Dividend Per Share Growth | 40.00% | - | - | 100.00% | - |
Dividend Yield | 2.42% | - | - | 1.22% | 0.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.08 | 7.16 | 7.16 | 10.98 | 18.21 | - |
Forward PE | - | 6.38 | 6.38 | 5.79 | 44.36 | - |
P/FCF Ratio | 12.16 | 7.28 | 4.97 | 18.93 | - | - |
PS Ratio | 1.14 | 1.34 | 1.34 | 2.04 | 2.18 | 4.18 |